To commemorate 'World Sight Day', Glaucoma Australia and its Patron, the Governor-General of Australia, His Excellency the Honourable David Hurley, are pleased to announce the 2022 recipient of the charity’s ‘Quinlivan’ Research Grants Program.
To celebrate World Sight Day and this year’s theme of #loveyoureyes, the Royal Victorian Eye and Ear Hospital has shared the story of one of their glaucoma patients with the hopes of raising awareness about the importance of eye-drop treatment adherence.
Glaukos Corporation has announced positive data for Phase 3 trials of iDose TR.
My sister, who is four years older than I am, went to her local hospital, the Queen Elizabeth in Glasgow, Scotland.
A recent study from the New York Eye and Ear Infirmary of Mount Sinai showed that being of African heritage increased the risk of vision loss due to glaucoma.
An invited review of the available literature on migraine and its impact on testing for glaucoma was published in 2016.
I had suffered migraines for years on and off but then started feeling like my eyes were wanting to explode, like there was a heaviness to them and a lot of pressure.
It was a pleasure for Glaucoma Australia’s CEO, Richard Wylie, to attend the Women in Business and Agriculture SA Inc (WAB) annual general meeting.
The first patient has been enrolled in a prospective, randomised, multicentre study to investigate canaloplasty with the new iTrack Advance CATALYST Study.